Whistleblower Law Collaborative, LLC

The Whistleblower Law Collaborative is one of the nation’s leading whistleblower law firms representing persons or companies who learn of fraud and step forward to expose wrongdoing. Our attorneys all have prior government experience and a passion for fighting fraud. We achieve outstanding results in this very complex area of the law, while supporting our courageous clients every step of the way.

Latest from Whistleblower Law Collaborative, LLC - Page 2

Whistleblower Law Collaborative Co-Founder and Managing Partner Suzanne Durrell was featured in the latest issue of Corporate Crime Reporter.  Her interview covers her newly announced Taxpayers Against Fraud Education Fund national COVID-19 Anti-Fraud Task Force. In the race to find a cure, the government is engaging in a public/private partnership with industry. Our bar is concerned that we are going to need a vast public/private partnership as well with whistleblowers and attorneys to keep…
DOJ announced that CWD Holdings LLC, an auto brakes importer, agreed to pay $8 million to resolve allegations that it violated the False Claims Act by committing customs fraud.  According to the government, CWD falsely claimed its product was unmounted brake pads, which have no customs duty.  In fact, CWD imported mounted brake pads subject to a 2.5% customs duty. CWD Engaged in Customs Fraud Through Misclassification CWD falsely described its brake pads as…
On July 30, 2020 at 1 pm ET, Whistleblower Law Collaborative will co-host a webinar in conjunction with the American Bar Association, Charles River Associates and Ropes & Gray focused on Covid Fraud and Risk.  The webinar is titled DOJ Enforcement in the COVID-19 Crisis: What to Expect and How to Mitigate Risk. The Department of Justice and the FBI are dealing with demanding new enforcement issues in addition to long-standing pre-COVID priorities.…
Today we bring you another story of the ever present “Florida Man.” Now profiting through Covid fraud by obtaining $4 million from the Payroll Protection Program to buy a Lamborghini Huracan EVO, among other goodies. But we begin by setting the mood with the immortal words of Janis Joplin: Oh Lord, won’t you buy me a Mercedes Benz My friends all drive Porsches, I must make amends Worked hard all my lifetime, no help from…
In March, DOJ intervened in our lawsuit alleging that Mallinckrodt ARD defrauded the Medicaid Drug Rebate Program (MDRP). Our client, James Landolt, filed a qui tam complaint on behalf of the United States as well as numerous States, the District of Columbia, and Puerto Rico. His complaint alleges that Mallinckrodt violated federal and state False Claims Acts by failing to pay hundreds of millions of dollars in Medicaid rebates for its high-priced drug Acthar.  States Join Our Mallinckrodt Lawsuit In June, twenty-six states, the District of…
As whistleblower lawyers and former prosecutors, we have seen a lot.  One of the most enjoyable aspects of both of those roles is the wide (and wild) variety of “fact patterns” that present themselves in the cases we have handled over the decades.  A recent Medicaid home health care fraud prosecution offers some lessons to would-be criminals in what not to do. After a while, one notices how cases have similar patterns but also their…
A version of this article appeared on Law 360: Expert Analysis on July 8, 2020. On June 25, in Ruckh v. Salus Rehabilitation, LLC, No. 18-10500 (11th Cir. June 25, 2020), the U.S. Court of Appeals for the Eleventh Circuit restored a jury’s verdict under the False Claims Act. At trial, the plaintiff persuaded the jury that the defendants had defrauded Medicare for years by misrepresenting the level of services they provided. U.S. District Judge…
Medicaid cannot negotiate drug prices the way private insurers can. This creates a risk that the public will overpay for needed drugs. The Medicaid Drug Rebate Program requires manufacturers to pay rebates to state Medicaid programs so that they do not overpay for drugs. The program is complicated. It is also vulnerable to several types of fraud. Below we explain how it works, and how drug companies can and do defraud it. We also give…
Medicaid cannot negotiate drug prices the way private insurers can. This creates a risk that the public will overpay for needed drugs. The Medicaid Drug Rebate Program requires manufacturers to pay rebates to state Medicaid programs so that they do not overpay for drugs. The program is complicated. It is also vulnerable to several types of fraud. Below we explain how it works, and how drug companies can and do defraud it. We also give…
Earlier this month, the Taxpayers Against Fraud Education Fund (TAFEF) formally announced the launch of a national COVID-19 Anti-Fraud Task Force. The Task Force will assist federal and state law enforcement in identifying, exposing, and prosecuting fraud related to COVID-19. It consists of former government prosecutors and experienced False Claims Act qui tam attorneys. Collectively, these attorneys have assisted federal and state governments in recovering over $20 billion.  The Task Force is chaired by…